The time we are spending on digital devices is on the rise, and it’s unlikely to slow down any time soon. With more and more apps, games, and social media options, we have all become more dependent on smartphones, tablets, and other electronic devices.
A new compact, portable device for rapid, high-definition meibomian gland imaging (LipiScan, TearScience) is an efficient screening tool for patients with complaints of dry eye and/or candidates for surgical procedures in which pre-existing dry eye could affect outcomes.
Ron Melton, OD, FAAO, and Randall Thomas, OD, MPH, FAAO, discussed common practices for treating dry eye, meibomian gland dysfunction (MGD), and blepharitis at the American Optometric Association (AOA) annual meeting. Here are a few medical management pearls from their discussion.
There may be a correlation between a person’s preferred sleep position and the health of his or her meibomian glands, said David Alevi, MD. Speaking at ASCRS 2016, Dr. Alevi said meibomian gland dysfunction (MGD) is thought to be a leading cause of dry eye, and often presents with similar symptoms.
Obstructive meibomian gland dysfunction is a common cause of dry eye disease. Performing lid massage using a specialized forceps improves meibum secretion with corresponding improvements in dry eye-related signs and symptoms.
Anyone who treats ocular surface disease (OSD) recognizes the important role oral antibiotics play in therapy, especially in patients with meibomian gland dysfunction (MGD). Yet the existing evidence is insufficient to conclude the effectiveness of oral antibiotic therapy, according to a report published in Ophthalmology.